Can one device do the job of two? TAVR study tests simpler artery closure

NCT ID NCT06871774

Recruiting now Disease control Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using just one Perclose device to close the artery after TAVR is as safe and effective as the usual two devices. Researchers will measure bleeding time and complications in 300 adults undergoing TAVR. The goal is to see if a simpler approach can reduce procedure time and risks.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Perclose vascular closure device
What this could lead to: If one device works as well as two, it could simplify the TAVR procedure, reduce costs, and shorten recovery time.
What could go wrong: This is a small, early-stage trial focused on procedural technique, not a new treatment. Using one device might increase the risk of bleeding or complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Aortic Valve Disease aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TRANSCATHETER AORTIC VALVE REPLACEMENT

Contacts and locations

Locations

Aurora St. Luke's Medical Center
RECRUITING

Milwaukee, Wisconsin, 53215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.